+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Measuring dyspepsia-related health in randomized trials: the Severity of Dyspepsia Assessment (SODA) and its use in treatment with NSAIDs and COX-2-specific inhibitors



Measuring dyspepsia-related health in randomized trials: the Severity of Dyspepsia Assessment (SODA) and its use in treatment with NSAIDs and COX-2-specific inhibitors



Rheumatology 42(Suppl. 3): Iii32



Dyspepsia is a common problem that is important from the perspectives of both patient health and economics. While there has been variability in the definitions used to describe dyspepsia, there have also been few standardized outcomes tools designed to measure dyspepsia-related health, especially in relation to changes in dyspepsia over time. An evaluative tool was developed, the Severity of Dyspepsia Assessment (SODA), which takes into account the multidimensional nature of dyspepsia using three scales (Pain, Non-pain Symptoms, and Satisfaction with Dyspepsia-related Health) and demonstrates good psychometric properties with respect to validity, reliability and sensitivity to change in the measurement of dyspepsia-related health. Although originally developed for the assessment of uninvestigated dyspepsia, the validation of SODA for use in clinical trials suggested its ability to compare treatment effects of non-specific non-steroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase (COX)-2-specific inhibitors. In comparative trials of celecoxib or valdecoxib with non-specific NSAIDs, COX-2-specific inhibitors were demonstrated to have superior dyspepsia tolerability than non-specific NSAIDs. These data demonstrate that SODA is an effective instrument for measuring dyspepsia-related health with a broad range of applications.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012291947

Download citation: RISBibTeXText

PMID: 14585916

DOI: 10.1093/rheumatology/keg496


Related references

SODA (severity of dyspepsia assessment): A new effective outcome measure for dyspepsia-related health. Journal of Clinical Epidemiology 54(8): 755-765, 2001

Validation of a modified version of SODA questionnaire (severity of dyspepsia assessment) adapted to Peru for evaluating evolution of symptoms severity in patients with dyspepsia. Revista de Gastroenterologia del Peru 33(1): 9, 2014

Reliability, validity, and responsiveness of Severity of Dyspepsia Assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy. American Journal of Gastroenterology 97(1): 32-39, 2002

New psychometric data from the Spanish versions of the Glasgow Dyspepsia Severity Score and the Dyspepsia-Related Health Scale measures. Revista Espanola de Enfermedades Digestivas 110(1): 10-18, 2018

Modified Severity of Dyspepsia Assessment pain scale: a new tool for measuring upper abdominal pain in osteoarthritis patients taking NSAIDs. Patient Related Outcome Measures 2: 135-143, 2011

The Leeds Dyspepsia Questionnaire: A valid tool for measuring the presence and severity of dyspepsia. Alimentary Pharmacology & Therapeutics 12(12): 1257-1262, 1998

The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Alimentary Pharmacology and Therapeutics 12(12): 1257-1262, 1998

Clinical trials in nonulcer dyspepsia (NUD): a cautionary note. A closer look at "a double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia". Canadian Journal of Gastroenterology 11(2): 125-126, 1997

Validation of phone interview for follow-up in clinical trials on dyspepsia: evaluation of the Glasgow Dyspepsia Severity Score and a Likert-scale symptoms test. European Journal of Gastroenterology and Hepatology 12(8): 949-953, 2000

Patient-based assessment in dyspepsia: development and validation of Dyspepsia Symptom Severity Index (DSSI). Digestive Diseases and Sciences 45(6): 1172-1179, 2000

Treatment of NSAIDs related dyspepsia. Gastroenterologie Clinique et Biologique 28 Spec no 3: C73-C76, 2004

Evaluating dyspepsia-related health measures How does SODA stack up?. Gut 47(Suppl. 1): A109-A110, 2000

Dyspepsia-related quality of life. Spanish adaptation and validation of the questionnaire Dyspepsia-Related Health Scale. Medicina Clinica 117(15): 567-573, 2001

Do NSAIDs cause dyspepsia? A meta-analysis evaluating alternative dyspepsia definitions. American Journal of Gastroenterology 97(8): 1951-1958, 2002

Evaluation of the severity of dyspepsia assessment in children The SODA for Children outcomes measure. Gastroenterology 122(4 Suppl 1): A-466, 2002